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Abstract
Surface disinfectants are part of broader preventive strategies preventing the transmission of bacteria, fungi and viruses in
medical institutions. To evaluate their virucidal efficacy, these products must be tested with appropriate model viruses with
different physico-chemical properties under conditions representing practical application in hospitals. The aim of this
study was to evaluate a quantitative carrier assay. Furthermore, different putative model viruses like adenovirus type 5 (AdV-
5) and different animal parvoviruses were evaluated with respect to their tenacity and practicability in laboratory handling.
To evaluate the robustness of the method, some of the viruses were tested in parallel in different laboratories in a multi-
center study. Different biocides, which are common active ingredients of surface disinfectants, were used in the test. After
drying on stainless steel discs as the carrier, model viruses were exposed to different concentrations of three alcohols,
peracetic acid (PAA) or glutaraldehyde (GDA), with a fixed exposure time of 5 minutes. Residual virus was determined after
treatment by endpoint titration. All parvoviruses exhibited a similar stability with respect to GDA, while AdV-5 was more
susceptible. For PAA, the porcine parvovirus was more sensitive than the other parvoviruses, and again, AdV-5 presented a
higher susceptibility than the parvoviruses. All parvoviruses were resistant to alcohols, while AdV-5 was only stable when
treated with 2-propanol. The analysis of the results of the multi-center study showed a high reproducibility of this test
system. In conclusion, two viruses with different physico-chemical properties can be recommended as appropriate model
viruses for the evaluation of the virucidal efficacy of surface disinfectants: AdV-5, which has a high clinical impact, and
murine parvovirus (MVM) with the highest practicability among the parvoviruses tested.
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Vereinigung zur Bekämpfung der Viruskrankheiten e.V. – DVV’’ (German Registered Association for Combating Viral Diseases). The DVV had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: JS is a consultant of MikroLab GmbH. IR is an employee of Labor Dr. Merk & Kollegen. There are no patents, products in development or
marketed products to declare. This does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.
* E-mail: eggers@labor-enders.de
Introduction
Nosocomial virus infections can prove fatal to people who are
particularly vulnerable to infections. This population includes
premature infants, people with chronic or degenerative illnesses,
immuno-compromised patients and the elderly. In these groups,
viral gastroenteritis due to rotaviruses or noroviruses, which are
normally self-limiting infections, represent a harmful risk [1,2,3].
The same applies to respiratory viruses such as influenza,
parainfluenza, enteroviruses or respiratory syncytial virus (RSV),
as was recently demonstrated by a large RSV outbreak in an adult
hematology unit in Heidelberg [4,5,6,7]. In particular, non-
enveloped viruses may persist on surfaces for several days or even
months [8] and can be transferred directly from contaminated
surfaces to susceptible patients [9,10]. Therefore, the disinfection
of surfaces frequently touched by patients and staff such as door
handles, faucets, and railings plays an important role in the
prevention and control of viral outbreaks in healthcare settings.
Considering that non-enveloped viruses such as noroviruses and
enteroviruses are resistant to the majority of chemical disinfec-
tants, only biocides with proven virucidal efficacy can be used.
This can only be achieved by ensuring that disinfectants pass a
virucidal activity test performed in compliance with good
laboratory practice and country-specific standards. In Europe,
EN 14476 describes the standard for determining virucidal
activity, which involves two non-enveloped viruses and a
quantitative suspension assay [11]. This quantitative suspension
test is performed in a test tube. The shortcoming of this assay is
that the virus particles are suspended in a large volume of
disinfectant, which makes inactivation of viruses easier due to the
high amount of contact between the disinfectant and virus
particles.
Therefore, suspension tests do not reflect real conditions. In
practice, viruses are immobilized on objects and/or work surfaces
with a high protein load from body fluids, which may protect
viruses from disinfection. To ensure that surface disinfectants are
able to inactivate microorganisms, they must be tested for their
efficacy under close to real-life conditions. This type of practical
assay has long been standardized for the testing of the bactericidal
activity of chemical disinfectants [12,13,14]. Bactericidal disinfec-
tants are tested stepwise according to European test principles,
beginning with a suspension test (EN phase 2, step 1) and then a
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quantitative non-porous carrier test simulating practical conditions
(EN phase 2, step 2) [14,15]. In contrast to the test for bactericidal
activity, until now, no European standard for virucidal efficacy
testing that simulates practical conditions exists. Such a test should
be based on model viruses that can be dried on carriers. The
choice of model viruses is of great importance when establishing
such a carrier test. The requirements for model viruses are as
follows: high resistance to disinfectants and drying, combined with
simple virus propagation in cell culture. The model viruses that are
already being used in the suspension test and that fulfill these
requirements can be taken into account. In the suspension test,
according to EN 14476 (phase 2/step 1), poliovirus type 1 LSc-2ab
and adenovirus type 5 strain (AdV-5) Adenoid 75 are used as
model viruses. Both viruses are suitable with respect to their
resistance to active ingredients, but polioviruses have some
drawbacks. In general, the use of poliovirus is only temporary,
and in the future, such use will require higher biosafety levels
because of the global polio eradication program, which was
initiated by the World Health Organization (WHO) in 1988 [16].
Furthermore, poliovirus infectivity is significantly decreased after
drying [17].
Therefore, poliovirus should be replaced with an alternative
model virus. For this purpose, animal parvoviruses such as the
bovine parvovirus (BPV) strain Haden, which is used for
chemothermal disinfection in the quantitative suspension test
and a national surface test [11,18,19], can be used because of their
known environmental stability and their practicability for labora-
tory use and because they do not pose any hazard to employees
performing the tests. However, BPV is not ideal because this
single-stranded DNA virus requires primary cells for replication,
meaning that it is difficult to handle in a routine testing laboratory.
In contrast, other animal parvoviruses, such as minute virus of
mice (MVM), porcine parvovirus (PPV), and canine parvovirus
(CPV), are cultivable on continuously growing cells and are
comparable to bovine parvovirus in terms of stability. Thus, they
can be chosen as model viruses for a carrier test.
Objectives
Our study was designed to address two objectives, which are
both important for efficacy testing of surface disinfectants. The
first aim was to establish a virucidal quantitative carrier test that
simulates practical conditions in a similar manner to the long-
established bactericidal carrier test. Viruses were dried on stainless
steel discs and exposed to different biocides, which are common
ingredients of commercial surface disinfectants.
The second aim was to choose and evaluate reliable model
viruses for such a test using AdV-5 and different animal
parvoviruses. MVM strain Crawford, PPV strain NADL-2 and
CPV type 2 were compared with BPV, which is already used to
test chemo-thermal inactivation [11,18]. For murine and porcine
parvoviruses, the investigation was performed as a multi-center
study in order to evaluate the inter-laboratory robustness of this
method.
Materials and Methods
Viruses and cell cultures
Bovine, canine, murine and porcine parvovirus (PV) and AdV-5
were used in the experiments. Test virus suspensions were
prepared by infecting susceptible cells with different multiplicities
of infection (MOI). For BPV (strain Haden, provided by Prof.
Böhm, University of Hohenheim, Stuttgart, Germany), fibroblastic
bovine embryonic lung (BEL) cells were used (established and
propagated by Labor Prof. Enders, MOI 1); for canine PV type 2
(CPV) (kindly provided by Prof. Truyen,University of Leipzig,
Leipzig, Germany), CRFK cells were used (provided by Dr. Riebe
of the Collection of Cell Lines in Veterinary Medicine (CCLV),
Friedrich-Loeffler-Institute, Isle of Riems, Germany, MOI 0.1); for
murine PV (MVM [minute virus of mice], strain Crawford,
ATCC VR-1346), A9 cells were used (European Cell Culture
Collection (EACC No 85011426) provided by Paul-Ehrlich-
Institute, Langen, Germany, MOI 1.0); for porcine PV (PPV;
strain NADL-2, ATCC VR-742), PK13 cells were used (ATCC
CRL 6489 provided by Paul-Ehrlich-Institute, MOI 1); and for
AdV-5 (strain Adenoid 75, ATCC VR-5), A549 cells (ATCC
CCL-185, MOI 0.01) were used.
Isolation and culture of primary bovine embryonic lung
fibroblasts
Bovine embryonic lung cell cultures were prepared from a
5-month-old calf fetus. In brief, the lung was cut into tiny pieces.
The cut tissue was transfered into sterile 100 mL beaker with
sterile stir bar and floated on 700 ml trypsine/EDTA solution
(Biochrome, Berlin, Germany), stirring slowly for 90 min. The
solution containing tissue fragments was transferred to sterile
50 mL tubes and media was added. The 50 mL tubes were spin at
1500 rpm for 10 min. The supernatant was removed and the
pellet washed twice with 10 mL of MEM media with 10% FBS.
Then the pellet was resuspended in 20 mL of DMEM media with
20% FBS and 1% antibiotic/antimycotic and transfered to a T75
tissue culture flask (Greiner Bio-one, Frickenhausen, Germany).
The primary cells were incubated at 37uC, 5%CO2 and checked
every day for fibroblasts and media colour. The trypsine
procedure was repeatedly performed with the remaining lung
tissue. After 7 days, fibroblasts of 3 different harvests exists and
were stored in liquid nitrogen until used.
Virus propagation
After virus inoculation of the cells, the supernatant was replaced
by a suitable cell culture medium: for PPV, Iscove’s Modified
Dulbecco’s Medium (IMEM), Biochrom AG, Germany; for
MVM, PPV and BPV, Dulbecco’s minimum essential medium
(DMEM, Sigma-Aldrich, Germany); for AdV-5, minimum essen-
tial medium (MEM, Biochrom AG, Germany) with 10% (for
MVM), 5% (for PPV) or 1% (for adenovirus) fetal calf serum (FCS,
Sigma-Aldrich, Germany). The cells were incubated at 37uC until
70–95% of the cells exhibited a cytopathic effect (for adenovirus,
approximately 10–12 days; for parvoviruses, 10–14 days). The
cells were frozen and thawed twice, followed by centrifugation at
1600 g for 10 minutes. The supernatant was aliquoted as test virus
suspensions and stored at 280uC.
Biocides
Five biocides were used in this study: glutaraldehyde (GDA)
(2500, 2000, 1000, 500, 125 ppm), peracetic acid (PAA) (1500,
1000, 500, 200, 50 ppm), ethanol (60, 55, 50, 45, 40%, v/v),
1-propanol (60, 50, 40, 30, 20, 10%, v/v) and 2-propanol (60, 50,
40, 30, 20%, v/v).
Dilutions of PAA, GDA and the alcohols (Sigma-Aldrich,
Seelze, Germany) were prepared with hard water (300 ppm
CaCO3, pH 7.0 - in accordance with EN 14476) immediately
before the inactivation experiments [11].
Preparation of virus inoculum
Nine volumes of test virus suspension were mixed with one
volume of 0.3% w/v of bovine serum albumin (BSA, clean
Carrier Test for Virucidal Surface Disinfection
PLOS ONE | www.plosone.org 2 January 2014 | Volume 9 | Issue 1 | e86128
conditions), resulting in a final BSA concentration of 0.03% in the
virus inoculum.
Disc washing
The cleaning of the stainless steel discs (20 mm diameter, GK
Formblech GmbH, Berlin, Germany) was performed as already
described [20,21]. In brief, prior to use, the discs were placed in a
container with an appropriate quantity of 5% (V/V) Decon 90 for
60 min, in a manner that the discs don’t stick together.
Subsequently, the discs were rinsed with running freshly distilled
water for 10 seconds. The rinsing was repeated with double
distilled water for a further 10 seconds in order to ensure complete
removal of the surfactant. Then, the the discs were diped in a bath
containing 70% (V/V) ethanol for 15 min. At the end, the discs
were removed and rinsed with double distilled water for at least
10 seconds. Sterilization was done by autoclaving.
Preparation of the carriers and test performance
A total of 50 ml of the virus inoculum was deposited on each
pre-treated carrier and dried in a desiccator (700–800 mbar, for
30 min). Then, the discs were transferred into plastic vial holders
(Sarstedt AG & Co. KG, Nümbrecht, Germany) containing 0.5 g
glass beads (0.25–0.50 mm diameter, Carl Roth GmbH, Karls-
ruhe, Germany), covered with 100 ml of the biocide (for the
control carriers t5 min, 100 ml of hard water was applied) and
incubated for 5 minutes. Immediately at the end of the exposure
time, 900 ml of ice-cold culture medium was added to stop the
activity of the biocides. Vials were vortexed for 1 min to recover
the residual viruses, and the eluate was immediately diluted
10-fold for determining viral infectivity. For the recovery rate,
50 ml of the virus inoculum was deposited on each pre-treated
carrier and was analyzed without drying (inocculum control). The
t0 min control was immediately determined after drying. All tests
were carried out at ambient temperatures of 20–22uC with three
replicates (carriers) and a minimum of two independent experi-
ments conducted on different days.
Determination of the infectivity and statistical analysis
Infectivity was determined by transferring 100 ml of each
dilution into eight wells of a 96-well microtiter plate with
permissive cells. The cell cultures were monitored for cytotoxic
effects for the same incubation time as described for the virus
propagation.
Virus titers were determined using the methods of Spearman
[22] and Kaerber [23] and expressed as log10TCID50/ml,
including standard deviation. The control titer of the different
viruses ranged from 5.66106 to 3.76108 TCID50/ml (in detail: the
titer ranges for AdV-5 were from 0.26107 to 3.76108 TCID50/
ml; for BPV, from 0.26107 to 0.86108; for CPV, from 0.36106 to
0.46106; for MVM, from 5.66105 to 2.56108; and for PPV, from
6.36105 to 8.36106). Titer reduction is presented as the difference
between the virus titer of the water control and the test sample
exposed to the biocide. This difference is given as the log10
reduction factor (log10 RF), including its 95% confidence interval
(CI) [18]. A 4-log10 reduction is required for efficacy (an
inactivation of 99.99%). Biologically relevant log10 RF differences
between viruses or laboratories were defined as $1 step
considering the lower and upper bounds of the 95% CI [24].
Significant differences were calculated from at least 6 parallel
titrations.
Participants
Five German laboratories participated in this study – referred to
as Lab 1, Lab 2, Lab 3, Lab 4, and Lab 5. Participation was open
and free of charge to all laboratories.
Results
The concentrations of the biocides used here were chosen to
allow us to observe kinetics and the transition from non-efficient to
efficient virus inactivation. The participating laboratories tested all
biocide concentrations on 2 test days and performed the test on
triplicate carriers per test day. The difference in the virus titer
before and after drying on the carriers was ,0.5 log10 (Tab. 1).
However, because each laboratory used its own virus stock, the
different titers of the test virus suspension from the different labs
are, to some extent, responsible for any inter-laboratory and inter-
virus log10 RF differences (Tab. 1 and Tab. 2).
For ethanol and 1-propanol, virucidal efficacy was observed
only for AdV-5 (Tab. 1), and all parvoviruses were not sufficiently
inactivated (Tab. 2). At concentrations $55% (v/v) for ethanol
and $30% (v/v) for 1-propanol, the titer reduction for AdV-5 was
at least 4 log10 steps (Tab. 1). Only low inactivation was observed
with 2-propanol.
A $4 log10 inactivation of AdV-5 was also detected for GDA at
concentrations of 125 to 500 ppm (Tab. 1). Furthermore, a
concentration-dependent increase of the virucidal efficacy of GDA
was detectable for all parvoviruses. GDA at 500 ppm was not able
to sufficiently reduce parvovirus titers (Tab. 2). At concentrations
of 2500 ppm, a 4 log10 reduction of only MVM was detected,
although residual virus could still be found (Fig. 1 a). Whereas PPV
showed similar kinetic as BPV (Fig. 2 a). Testing CPV, a 99.99%
reduction was limited by the cytotoxicity and/or the titer of the
virus inoculum used (Tab. 2). Therefore, in some cases, the log10
RFs are marked with ‘‘$’’, indicating that the determination of the
log10 RF was limited due to cytotoxicity.
With respect to PAA, a concentration-dependent log10 RF
increase could be observed for all parvoviruses (Tab. 2). MVM was
as resistant to PAA as BPV (Fig. 1 b), while PPV was more
susceptible to PAA (Fig. 2 b). For AdV-5, an log10 RF $4 was
detected at PAA concentrations #1000 ppm (Tab. 1).
In summary, our data reveal a concentration-dependent
virucidal efficacy for the biocides. All parvoviruses have a similar
level of stability when treated with GDA, while PPV is more
sensitive to PAA than the others. Additionally, AdV-5 exhibited
higher susceptibility when compared to the parvoviruses.
For the five biocides, all log10 RF data were compared with
regard to relevant intra- and inter-laboratory differences of the
tested viruses. No such biologically relevant differences were
observed for MVM and PPV when treated with GDA and PAA.
In one case, the inactivation kinetics of PPV resulted in an inter-
laboratory heterogeneous (non-relevant) discrepancy between two
labs (500 ppm PAA). Furthermore, no intra-laboratory differences
were demonstrated for all tested viruses (Tab. 1 and 2).
Discussion
Although surface disinfection with virucidal products is an
important tool in the prevention of nosocomial viral infections,
information on the efficacy of virucidal disinfectants is still missing.
Disinfection research in virology is somewhat neglected, although
prevalence studies and personnel monitoring have shown
contamination hazards [25]. The useful dilutions and contact
time of virucidal surface disinfectants are still based on concen-
trations that will pass either an European suspension test, that is,
Carrier Test for Virucidal Surface Disinfection
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Table 1. Concentration-dependent virucidal activity of 5 biocides against Ad-5.
adenovirus type 5
biocide Lab 1 Lab 2 Lab 5
log10 TCID50/ml log10 RF ±95%CI log10 TCID50/ml log10 RF ±95%CI log10 TCID50/ml log10 RF±95%CI
control inocculum 8.05 7.26 n.t.
t0 min n.t. 6.61 n.t.
t5 min 8.14 6.42 6.70
GDA (ppm) 125 5.45 2.6960.50 1.57 4.8560.45 2.18 4.5260.50
500 2.36 5.7761.23 1.50 4.9260.44 1.50 5.2060.54
1000 1.86 6.2760.35 1.50 4.9260.44 1.50 5.2060.54
2000 1.86 6.2760.35 2.50 3.9260.44 1.50 5.2060.54
2500 1.80 6.3460.32 2.50 3.9260.44 1.50 5.2060.53
control inocculum n.t. 7.26 n.t.
t0 min n.t. 6.61 n.t.
t5 min 7.63 6.42 7.44
PAA (ppm) 50 7.65 20.0260.38 6.44 20.0260.59 7.17 0.3360.54
200 7.21 0.4160.58 1.84 4.5860.68 4.02 2.9260.52
500 4.82 2.8160.96 1.50 4.9260.44 1.99 5.4560.53
1000 2.50 5.1360.25 1.50 4.9260.44 1.67 5.7760.45
1500 2.52 5.1160.26 1.50 4.9260.44 1.50 5.9460.36
control inocculum n.t. 7.13 n.t.
t0 min n.t. 6.50 n.t.
t5 min 8.18 6.67 7.73
ethanol (v/v) 40% 7.95 0.2360.90 5.98 0.6960.39 3.64 2.5560.52
45% 6.80 1.3860.79 n.t. n.t. n.t. n.t.
50% 6.28 1.9061.39 5.04 1.6360.55 1.50 6.2360.41
55% 3.26 4.9261.11 1.54 5.1360.31 1.50 6.2360.41
60% 2.68 5.5060.55 1.50 5.1760.30 1.50 6.2360.41
control inocculum n.t. 7.38 n.t.
t0 min n.t. 6.77 n.t.
t5 min 8.32 6.65 7.21
1-pro-panol
(v/v)
10% 8.18 0.1560.00 5.69 0.9660.45 6.93 0.2860.54
20% 7.72 0.6060.39 5.52 1.1360.91 1.55 5.6660.41
30% 3.05 5.2760.87 1.54 5.1160.39 1.50 5.7160.40
40% 2.70 5.6360.51 1.67 4.9860.43 1.50 5.7160.40
50% 2.39 5.9460.62 1.61 5.0460.47 1.50 5.7160.40
60% 3.80 4.5260.75 1.90 4.7560.45 1.50 5.7160.40
control inocculum n.t. 7.38 n.t.
t0 min n.t. 6.77 n.t.
t5 min 8.34 6.65 n.t.
2-pro-panol
(v/v)
20% 7.97 0.3760.27 n.t. n.t. n.t. n.t.
30% 7.68 0.6760.50 n.t. n.t. n.t. n.t.
40% 7.43 0.9260.36 6.08 0.5760.39 n.t. n.t.
50% 7.01 1.3360.40 n.t. n.t. n.t. n.t.
60% 7.10 1.2560.92 5.90 0.7560.39 n.t. n.t.
doi:10.1371/journal.pone.0086128.t001
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EN 14476, or a national standard, such as the German DVV/
RKI suspension test [11,18]. In order to improve time/concen-
tration relations of surface disinfectants which reflect dayly needs
in clinical surroundings further more practical testing is necessary.
Therefore, a virucidal quantitative carrier test that simulates
practical conditions was evaluated in this study. The method was
based on the EN 13697 standard for the following reasons [14,20]:
In 1993, experts from the veterinary, food, industrial, domestic
and institutional fields within the framework of CEN/TC 216
developed such a quantitative surface test for bactericidal and
fungicidal products that mimics real conditions [26]. Derived from
this work is the European standard EN 13697 [14], a quantitative
non-porous surface test for the evaluation of the bactericidal and/
or fungicidal activity of chemical disinfectants without mechanical
action (phase 2, step 2). Ring trials during the 1990s demonstrated
that this surface test, when using dried bacteria or fungi on
stainless steel carriers, could result in 10-fold lower reduction
factors than those obtained using suspension tests [13]. This
observations are also supported by studies of Peters and Spicher on
Staphylococcus aureus which showed an increased resistance to
formaldehyde, from 0.8% in the suspension test to 1.2% in the
surface test [27,28]. Based on this observatiuons, it is assumed that
virucidal disinfectants might also show an increased resistance in
the surface test. However, a virucidal surface test is required to
substantiate this notion and for further knowledge.
The next issue of this study was to find suitable candidates for
the test viruses of a surface test.. In Europe, model viruses that
cover a broad spectrum of physico-chemical properties have been
used for testing and verifying the efficacy of disinfectants under
practical conditions. Currently, poliovirus and AdV-5 are used by
the European Standard EN 14476 as model viruses for
quantitative suspension tests [11]. Poliovirus was excluded from
this study because it is relatively sensitive to the drying process,
with a loss of titer of approximately 3 log10 [17]. In addition, due
to the WHO polio eradication program, poliovirus will need to be
substituted with another model virus with similar properties in the
future. The thermoresistant virus BPV is used for the determina-
tion of the virucidal activity of chemothermal disinfection
procedures in both the EN 14476 and the DVV/RKI guideline.
However, BPV is difficult to grow in the laboratory. In contrast,
PPV and MVM are easy to propagate. Therefore, this study
investigated the suitability of AdV-5 and four different animal
parvoviruses (BPV, CPV, MVM, and PPV) as putative model
viruses that can potentially substitute for poliovirus.
One of the basic requirements for a model virus is stability
during a drying process. Our data showed that all of the viruses we
tested fulfill this requirement. The difference between the virus
titer before and after drying on the carriers was #0.5 log10 (data
not shown). This result was to be expected because all animal
parvoviruses are known to be very stable when exposed to
environmental influences such as chemicals or heat [29]. In
contrast, it is known that many enveloped viruses lose significant
infectivity meaning a small difference between virus after drying
and the limit of virus detection [30].
Furthermore, our results demonstrated that in all tests with
BPV, residual viruses were confirmed. Thus, 99.99% inactivation
could not be achieved using the tested conditions. Most of the
tested parvoviruses revealed similar log10 reductions with GDA
(Tab. 2). Only for PPV exposed to PAA was a 4 log10 reduction
achieved. Similar to results were found by Eterpi et al., the
parvoviruses (PPV, MVM) exhibited higher stability than the
adenovirus when exposed to different active substances and
disinfectants [29]. Our experiments showed also that GDA and
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reductions of $4 of the adenovirus was achieved by $250 ppm
(range 125 to 500) GDA, 500 ppm (range 200 to 1000) PAA.
While 1-propanol (30% v/v) was the most effective alcohol used to
inactivate AdV-5 on the carrier, for ethanol, higher concentrations
($55%) were needed. Treatment with 2-propanol did not result
in a 4 log10 reduction of AdV-5, even at a concentration of 60%
(v/v). Similar ranges for GDA, PAA, and Ethanol were fond in
study carried out by the virucidal task group of CEN/TC 216:
Adv-5 was inactivated in a carrier test by 500 ppm GDA,
#500 ppm PAA, and $60% (v/v) Ethanol (personal communi-
cation, Dr. Graziella Morace, VTG Project Leader of TC 216).
Variation in the activity range whether of different sources or
passages of viruses and cell lines were also found in the VTG
study. Therefore, reference test for virus inactivation with a
defined product (e.g. GDA and PAA) in parallel with a product
under test for internal control of the test is needed.
All PVs were stable against all tested alcohols (Tab. 2). Stability
against ethanol and 2-propanol has also been demonstrated
previously in tests with two parvoviruses (CPV and Kilham rat
virus), confirming our data [31]. Although in this study, BPV and
CPV demonstrated the highest stability, both viruses are difficult
to handle in the laboratory. In contrast, MVM reaches high viral
Figure 1. Concentration-dependent virucidal efficacy of a) glutaraldehyde and b) peracetic acid against MVM tested in 2 of the 5
laboratories compared to BPV (vertical lines indicate the 95% confidence intervals).
doi:10.1371/journal.pone.0086128.g001
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titers and is relatively uncomplicated to handle in the laboratory.
Our data on MVM reveal that the test accuracy across the
participating laboratories was relatively high, and the inactivation
kinetic was close to that of the established test virus BPV.
Therefore, along with MVM, AdV-5, despite its more fragile
character, seems to be an appropriate model virus, particularly
due to its biological properties and the importance of adenoviruses
in human medicine. Furthermore, due to the clinical impact of
human noroviruses, we recommend the additional use of murine
norovirus (MNV), a surrogate virus for human noroviruses, in
combination with AdV-5 and MVM for future guidelines or
standards that evaluate the virucidal efficacy of surface disinfec-
tants. In the revised version of prEN 14476:2013, MNV is
included as a test virus. In the food and industrial sectors, multiple
studies evaluating norovirus inactivation on surfaces have been
recently performed [21,32,33,34,35]. Some studies were carried
out using MNV on stainless steel carriers [21,35]. Magulski et al.
[21] tested the inactivating properties of several chemical biocides
Figure 2. Concentration-dependent virucidal efficacy of a) glutaraldehyde and b) peracetic acid against PPV tested in 3 of the 5
laboratories compared to BPV (vertical lines indicate the 95% confidence intervals).
doi:10.1371/journal.pone.0086128.g002
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using MNV. MNV demonstrated a similar stability during drying
as AdV-5 and parvoviruses. The virucidal susceptibility of MNV is
similar to those of PPV in our study [21]. Concentrations of
1500 ppm for PAA and 2500 ppm for GDA were needed to
inactivate 99.99% of MNV within 5 min [21]. However, the
activity range of alcohols was nearly the same as for AdV-5 in our
study. Ethanol (50%, v/v) and 1-propanol (30%, v/v) could
inactivate MNV-1 on stainless steel discs by 4 log10 units within
5 min, and 2-propanol was not active. As already mentioned, one
of the aims of our study was to evaluate the reproducibility of the
method used. We could show, that there were no considerable
intra- and inter-laboratory log10 RF differences discerned for the
PVs. The observed log10 RF discrepancies were found at
concentrations with low efficacy and might be caused by a
number of factors (e.g., the manner of the preparation of the test
virus suspension, limitations due to cytotoxic reactions, inactiva-
tion kinetics). Our study has some limitations that are based on the
nature of virus cultivation. For example, if all labs used viruses and
cells from the same origin at an identical passage number and
equal culture media, as well as under other identical conditions,
the results would perhaps differ to a lesser extent. On the other
hand, the performance of our study includes the biological variety
that appears during disinfectant testing. High standardization for
virus cultivation and reproducible measures to minimize cytotox-
icity are necessary for performing this method. Further standard-
ization of this method might be achieved by the introduction of
certain reference biocides with defined reference ranges, such as
GDA, PAA, or ethanol. This and further ring trials will contribute
to improving the comparability of virucidal tests between
laboratories.
Nevertheless, our results present a feasible method that enables
an efficacy assessment that simulates applications in hospital
settings.
Conclusion
Based on our results MVM and AdV-5 can be recommended as
appropriate model viruses for the evaluation of virucidal efficacy of
surface disinfectants. These viruses, together with MNV as a
surrogate of human norovirus, are well-suited model viruses for
test guidelines that simulate practical conditions for surface
disinfectants using stainless steel carriers as the surface. In
addition, all viruses can be cultivated to high titers and
demonstrate high stability during the drying process.
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